LabGenius Therapeutics

Description

LabGenius Therapeutics develops EVA, an automated platform for discovering and optimizing complex therapeutic antibodies. It supports internal work on selectivity-enhanced solid-tumour treatments.

Related

• Numab TherapeuticsNumab Therapeutics engineers multispecific antibodies. Its work supports a therapeutic pipeline based on antibody engineering and Swiss…
• Simurgh BioscienceDevelops drug candidates by discovering and isolating bioactive compounds from microorganisms for use by medical researchers and drug…
• ARTHEX BIOTECH S.L.Develops RNA-based therapeutics, specifically anti-miR oligonucleotides for myotonic dystrophy and other diseases, used by researchers and…
• Google DeepMindGoogle DeepMind develops artificial intelligence models and systems.
• brainjoDevelops therapeutic candidates and a pipeline for medical research; used for progressing projects and presenting project information to…
• BioInvent International ABBioInvent discovers and develops antibody-based immuno-oncology therapeutics; its tools and services support clinical trials, drug…
• Isomorphic LabsBuilds predictive and generative AI models for drug discovery, used to accelerate scientific discovery and design novel molecules for…
• Hoxton FarmsHoxton Farms is a London cultivated-fat and biomanufacturing company producing animal fat from stem cells for food manufacturers.
• Relation TherapeuticsBuilds AI-driven drug discovery and development platforms to identify biology and advance molecules to clinical value inflection points for…
• Confo TherapeuticsConfo Therapeutics develops small molecule and antibody-based therapeutics using proprietary GPCR-targeting technology for metabolic,…
• ENBIODevelops surface treatment products and coatings for thermal control, adhesion, and mould release used by manufacturers handling rubber,…
• ONK TherapeuticsONK Therapeutics develops ready-made natural killer cell therapies.